OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging trends in IRAK-4 kinase research
Himanshu Yadav, Raj Kumar Shirumalla
Molecular Biology Reports (2023) Vol. 50, Iss. 9, pp. 7825-7837
Closed Access | Times Cited: 10

Showing 10 citing articles:

TRIF-dependent signaling and its role in liver diseases
Lilin Hu, Zilu Cheng, Huikuan Chu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5

IRAK4: potential therapeutic target for airway disease exacerbations
Joseph A. Jude, Reynold A. Panettieri
Trends in Pharmacological Sciences (2025)
Closed Access

Recent advances in interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors and PROTACs
Yifan Feng, Chengjuan Chen, Anqi Shao, et al.
Chinese Chemical Letters (2025), pp. 110963-110963
Closed Access

Integrated multi-omics landscape of non-small cell lung cancer with distant metastasis
Teng He, Ting Jiang, Xiaoyuan Sun, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review
Ziqiang Liu, Qian Zhang, Yulin Liu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 111, pp. 117847-117847
Closed Access | Times Cited: 4

Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer
Yifan Feng, Chengjuan Chen, Anqi Shao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5091-5105
Open Access | Times Cited: 3

Advances in Targeted Therapies for Inflammatory Diseases and Cancer: Exploring Cellular Mechanisms and Therapeutic Strategies
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 758-760
Open Access | Times Cited: 2

Opportunities of Topical Drug Products in a Changing Dermatological Landscape
Wen‐Kai Hsiao, Michael E. Herbig, J. M. Newsam, et al.
European Journal of Pharmaceutical Sciences (2024), pp. 106913-106913
Open Access

IRAK2 overexpression restrains prostate cancer progression by regulation of TRAF6 ubiquitination
Yunfeng Shi, Chunfu Wu, Chengyue Wang, et al.
Cellular Signalling (2024) Vol. 125, pp. 111508-111508
Closed Access

Page 1

Scroll to top